Hiromi Sugimoto

625 total citations
23 papers, 525 citations indexed

About

Hiromi Sugimoto is a scholar working on Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hiromi Sugimoto has authored 23 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Physiology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hiromi Sugimoto's work include Receptor Mechanisms and Signaling (5 papers), Asthma and respiratory diseases (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Hiromi Sugimoto is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Asthma and respiratory diseases (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Hiromi Sugimoto collaborates with scholars based in Japan and United States. Hiromi Sugimoto's co-authors include Michitaka Shichijo, Kevin B. Bacon, Florian Gantner, Makoto Shimazaki, Akihiko Watanabe, Yutaka Sugie, Yoko Hiroaki, Yoshinori Fujiyoshi, Tomoko Doi and Kōichi Nagao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemistry and European Heart Journal.

In The Last Decade

Hiromi Sugimoto

21 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiromi Sugimoto Japan 12 186 185 130 72 65 23 525
Katsuo Ikezawa Japan 15 227 1.2× 249 1.3× 61 0.5× 66 0.9× 72 1.1× 47 585
Victoria Boswell‐Smith United Kingdom 8 247 1.3× 383 2.1× 138 1.1× 59 0.8× 76 1.2× 8 709
Mark T. Marino United States 12 102 0.5× 149 0.8× 66 0.5× 89 1.2× 11 0.2× 30 593
B Panczenko United States 6 166 0.9× 110 0.6× 307 2.4× 67 0.9× 24 0.4× 11 547
J.R. Boot United Kingdom 11 155 0.8× 159 0.9× 247 1.9× 59 0.8× 54 0.8× 21 523
David L. Saussy United States 11 182 1.0× 368 2.0× 48 0.4× 195 2.7× 79 1.2× 23 587
Susumu Otomo Japan 14 88 0.5× 356 1.9× 66 0.5× 207 2.9× 57 0.9× 73 657
C. S. McFarlane Canada 14 288 1.5× 199 1.1× 135 1.0× 47 0.7× 98 1.5× 20 619
Mariaconcetta Durante Italy 13 152 0.8× 272 1.5× 72 0.6× 39 0.5× 98 1.5× 19 522
Hitoshi Maegawa Japan 16 68 0.4× 233 1.3× 177 1.4× 57 0.8× 16 0.2× 26 664

Countries citing papers authored by Hiromi Sugimoto

Since Specialization
Citations

This map shows the geographic impact of Hiromi Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromi Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromi Sugimoto more than expected).

Fields of papers citing papers by Hiromi Sugimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromi Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromi Sugimoto. The network helps show where Hiromi Sugimoto may publish in the future.

Co-authorship network of co-authors of Hiromi Sugimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromi Sugimoto. A scholar is included among the top collaborators of Hiromi Sugimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromi Sugimoto. Hiromi Sugimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Tetsu, Taro Yasuma, Corina N. D’Alessandro‐Gabazza, et al.. (2020). Low-Dose of Intrapulmonary Pirfenidone Improves Human Transforming Growth Factorβ1-Driven Lung Fibrosis. Frontiers in Pharmacology. 11. 593620–593620. 7 indexed citations
2.
Hashimoto, Shigehiro, et al.. (2019). Effect of Couette Type of Shear Stress Field with Axial Shear Slope on Deformation and Migration of Cell: Comparison Between C2C12 and HUVEC. SHILAP Revista de lepidopterología.
3.
Hashimoto, Shigehiro, et al.. (2017). Effect of Flow on Cultured Cell at Micro-Pattern of Ridge Lines. SHILAP Revista de lepidopterología.
4.
Igarashi, Miho, et al.. (2014). The effects of personality and time perspective on depression and self-esteem in a longitudinal sample of college students. Personality and Individual Differences. 60. S43–S43. 2 indexed citations
5.
Yokoyama, Hiroki, Masato Matsushima, K. Kawai, et al.. (2011). Low incidence of cardiovascular events in Japanese patients with Type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20). Diabetic Medicine. 28(10). 1221–1228. 33 indexed citations
6.
Kasuya, Yoshitoshi, Keita Yamauchi, Hiromi Sugimoto, et al.. (2011). Cigarette smoke-induced pulmonary inflammation is attenuated in CD69-deficient mice. Journal of Receptors and Signal Transduction. 31(6). 434–439. 12 indexed citations
7.
8.
Sugimoto, Hiromi, et al.. (2009). In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT4 receptor. European Journal of Pharmacology. 609(1-3). 5–12. 4 indexed citations
9.
Sugie, Yutaka, et al.. (2008). Pharmacological Evaluation of a Novel Cannabinoid 2 (CB2) Ligand, PF-03550096, In Vitro and In Vivo by Using a Rat Model of Visceral Hypersensitivity. Journal of Pharmacological Sciences. 106(2). 219–224. 56 indexed citations
10.
Sugimoto, Hiromi, et al.. (2008). Contribution of Active and Inactive States of the Human 5-HT4d Receptor to the Functional Activities of 5-HT4–Receptor Agonists. Journal of Pharmacological Sciences. 107(3). 251–259. 8 indexed citations
11.
Kawai, Makoto, Yasuhiro Iwata, Tsutomu Masuda, et al.. (2008). The SAR studies of novel CB2 selective agonists, benzimidazolone derivatives. Bioorganic & Medicinal Chemistry Letters. 18(11). 3310–3314. 25 indexed citations
12.
Oishi, M., Hiroki Yokoyama, N. Abe, et al.. (2007). Time and cost involved in the care of newly registered patients with diabetes mellitus and other lifestyle diseases at diabetes clinics in Japan (JDDM 4). Diabetic Medicine. 24(10). 1149–1155. 6 indexed citations
13.
Sugimoto, Hiromi, Michitaka Shichijo, Mitsuhiro Okano, & Kevin B. Bacon. (2005). CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Δ12, 14-PGJ2- and indomethacin-induced agonist responses. European Journal of Pharmacology. 524(1-3). 30–37. 25 indexed citations
14.
Nakae, Koichi, Noriyuki Yamamoto, Satoru Yoshikawa, et al.. (2005). A Prostacyclin Receptor Antagonist Inhibits the Sensitized Release of Substance P from Rat Sensory Neurons. Journal of Pharmacology and Experimental Therapeutics. 315(3). 1136–1142. 20 indexed citations
15.
Sugimoto, Hiromi, et al.. (2003). A 5 Gbps CMOS frequency tolerant multi phase clock recovery circuit. 82–83. 3 indexed citations
16.
Shichijo, Michitaka, Hiromi Sugimoto, Kōichi Nagao, et al.. (2003). Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells Activation in Vivo Increases Blood Leukocyte Counts and Its Blockade Abrogates 13,14-Dihydro-15-keto-prostaglandin D2-Induced Eosinophilia in Rats. Journal of Pharmacology and Experimental Therapeutics. 307(2). 518–525. 59 indexed citations
17.
Sugimoto, Hiromi, Michitaka Shichijo, Akihiko Watanabe, et al.. (2003). An Orally Bioavailable Small Molecule Antagonist of CRTH2, Ramatroban (BAY u3405), Inhibits Prostaglandin D2-Induced Eosinophil Migration in Vitro. Journal of Pharmacology and Experimental Therapeutics. 305(1). 347–352. 132 indexed citations
18.
19.
Umeda, F., et al.. (1985). Effect of plasma, serum and platelets from diabetics on DNA synthesis in cultured vascular smooth muscle cells.. PubMed. 8(1). 35–40. 14 indexed citations
20.
Sugimoto, Hiromi, et al.. (1979). Effects of S-methylmethionine (vitamin U) on experimental nephrotic hyperlipidemia.. PubMed. 29(10). 1517–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuo Ikezawa Breakdown of academic impact, for papers by Victoria Boswell‐Smith Breakdown of academic impact, for papers by Mark T. Marino Breakdown of academic impact, for papers by B Panczenko Breakdown of academic impact, for papers by J.R. Boot Breakdown of academic impact, for papers by David L. Saussy Breakdown of academic impact, for papers by Susumu Otomo Breakdown of academic impact, for papers by C. S. McFarlane Breakdown of academic impact, for papers by Mariaconcetta Durante Breakdown of academic impact, for papers by Hitoshi Maegawa
Rankless by CCL
2026